Vericel Corporation

VCEL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-16.1M
Depreciation & Amortization $704.0K
Depreciation —
Amortization —
Stock-Based Compensation $1.4M
Net Cash from Operating Activities $-13.8M
Investing Activities
Capital Expenditures $35.0K
Business Acquisitions —
Net Cash from Investing Activities —
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities —
Net Change in Cash —
Free Cash Flow $-13.8M
← Newer Page 3 of 3 Older →